Literature DB >> 28282270

Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota.

Christopher Staley1, Byron P Vaughn2, Carolyn T Graiziger2, Stephanie Singroy1, Matthew J Hamilton1, Dan Yao3, Chi Chen3, Alexander Khoruts1,2, Michael J Sadowsky1,4.   

Abstract

Fecal microbiota transplantation (FMT) is a highly effective treatment of recurrent and recalcitrant Clostridium difficile infection (rCDI). In a recent study oral-delivery of encapsulated, freeze-dried donor material, resulted in comparable rates of cure to colonoscopic approaches. Here we characterize shifts in the fecal bacterial community structure of patients treated for rCDI using encapsulated donor material. Prior to FMT, patient fecal samples showed declines in diversity and abundance of Firmicutes and Bacteroidetes, with concurrent increases in members of the Proteobacteria, specifically Enterobacteriaceae. Moreover, patients who experienced recurrence of CDI within the 2-month clinical follow-up had greater abundances of Enterobacteriaceae and did not show resolution of dysbioses. Despite resolution of rCDI following oral-administration of encapsulated fecal microbiota, community composition was slow to return to a normal donor-like assemblage. Post-FMT taxa within the Firmicutes showed rapid increases in relative abundance and did not vary significantly over time. Conversely, Bacteroidetes taxa only showed significant increases in abundance after one month post-FMT, corresponding to significant increases in the community attributable to the donors. Changes in the associations among dominant OTUs were observed at days, weeks, and months post-FMT, suggesting shifts in community dynamics may be related to the timing of increases in abundance of specific taxa. Administration of encapsulated, freeze-dried, fecal microbiota to rCDI patients resulted in restoration of bacterial diversity and resolution of dysbiosis. However, shifts in the fecal microbiome were incremental rather than immediate, and may be driven by changes in community dynamics reflecting changes in the host environment.

Entities:  

Keywords:  16S rRNA; Capsule-delivered FMT; Clostridium difficile; cure; fecal microbial transplantation; microbial community structure; next-generation sequencing

Mesh:

Substances:

Year:  2017        PMID: 28282270      PMCID: PMC5479395          DOI: 10.1080/19490976.2017.1299310

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  35 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.

Authors:  K B M Saiful Islam; Satoru Fukiya; Masahito Hagio; Nobuyuki Fujii; Satoshi Ishizuka; Tadasuke Ooka; Yoshitoshi Ogura; Tetsuya Hayashi; Atsushi Yokota
Journal:  Gastroenterology       Date:  2011-08-10       Impact factor: 22.682

Review 3.  Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.

Authors:  Dimitri Drekonja; Jon Reich; Selome Gezahegn; Nancy Greer; Aasma Shaukat; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Ann Intern Med       Date:  2015-05-05       Impact factor: 25.391

4.  Evaluation of water sampling methodologies for amplicon-based characterization of bacterial community structure.

Authors:  Christopher Staley; Trevor J Gould; Ping Wang; Jane Phillips; James B Cotner; Michael J Sadowsky
Journal:  J Microbiol Methods       Date:  2015-05-06       Impact factor: 2.363

5.  Faecal microbiota transplantation is promising but not a panacea.

Authors:  Michael J Sadowsky; Alexander Khoruts
Journal:  Nat Microbiol       Date:  2016-02-24       Impact factor: 17.745

6.  Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.

Authors:  Matthew J Hamilton; Alexa R Weingarden; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Gastroenterol       Date:  2012-01-31       Impact factor: 10.864

7.  Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

Authors:  Ilan Youngster; George H Russell; Christina Pindar; Tomer Ziv-Baran; Jenny Sauk; Elizabeth L Hohmann
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

8.  Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.

Authors:  Alexa R Weingarden; Chi Chen; Aleh Bobr; Dan Yao; Yuwei Lu; Valerie M Nelson; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

9.  Ironing out the wrinkles in the rare biosphere through improved OTU clustering.

Authors:  Susan M Huse; David Mark Welch; Hilary G Morrison; Mitchell L Sogin
Journal:  Environ Microbiol       Date:  2010-03-11       Impact factor: 5.491

10.  Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

Authors:  Charlie G Buffie; Vanni Bucci; Richard R Stein; Peter T McKenney; Lilan Ling; Asia Gobourne; Daniel No; Hui Liu; Melissa Kinnebrew; Agnes Viale; Eric Littmann; Marcel R M van den Brink; Robert R Jenq; Ying Taur; Chris Sander; Justin R Cross; Nora C Toussaint; Joao B Xavier; Eric G Pamer
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

View more
  17 in total

1.  Fecal microbiota transplantation-early steps on a long journey ahead.

Authors:  Alexander Khoruts
Journal:  Gut Microbes       Date:  2017-04-10

Review 2.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.

Authors:  Alexander Khoruts; Christopher Staley; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-25       Impact factor: 46.802

Review 3.  The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection.

Authors:  Benjamin H Mullish; Jessica R Allegretti
Journal:  Therap Adv Gastroenterol       Date:  2021-05-28       Impact factor: 4.409

Review 4.  Fecal transplantation: digestive and extradigestive clinical applications.

Authors:  Mihaela Filip; Valentina Tzaneva; Dan L Dumitrascu
Journal:  Clujul Med       Date:  2018-07-31

5.  The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.

Authors:  Tarek Mazzawi; Gülen Arslan Lied; Dag André Sangnes; Magdy El-Salhy; Johannes R Hov; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

6.  Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.

Authors:  Alexander Khoruts; Michael J Sadowsky; Christopher Staley; Thomas Kaiser; Byron P Vaughn; Carolyn Graiziger; Matthew J Hamilton; Amanda J Kabage
Journal:  mBio       Date:  2019-07-23       Impact factor: 7.867

Review 7.  Application of Microbiome Management in Therapy for Clostridioides difficile Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents.

Authors:  Chun-Wei Chiu; Pei-Jane Tsai; Ching-Chi Lee; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Pathogens       Date:  2021-05-24

8.  Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.

Authors:  Christopher Staley; Thomas Kaiser; Byron P Vaughn; Carolyn T Graiziger; Matthew J Hamilton; Tauseef Ur Rehman; Kevin Song; Alexander Khoruts; Michael J Sadowsky
Journal:  Microbiome       Date:  2018-09-18       Impact factor: 14.650

9.  Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE).

Authors:  Siew C Ng; Michael A Kamm; Yun Kit Yeoh; Paul K S Chan; Tao Zuo; Whitney Tang; Ajit Sood; Akira Andoh; Naoki Ohmiya; Yongjian Zhou; Choon Jin Ooi; Varocha Mahachai; Chun-Ying Wu; Faming Zhang; Kentaro Sugano; Francis K L Chan
Journal:  Gut       Date:  2019-10-14       Impact factor: 23.059

10.  Transfer of skin microbiota between two dissimilar autologous microenvironments: A pilot study.

Authors:  Benji Perin; Amin Addetia; Xuan Qin
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.